中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks

文献类型:期刊论文

作者Wang, Shisheng1,2; Zhu, Hongwen3; Zhou, Hu3; Cheng, Jingqiu1,2; Yang, Hao1,2
刊名BMC BIOINFORMATICS
出版日期2020-10-07
卷号21期号:1页码:15
ISSN号1471-2105
关键词Raw mass spectrometry data Proteome profiling Feature swath extraction Deep neural networks Multi-tumor types Leave-one-out cross prediction strategy
DOI10.1186/s12859-020-03783-0
通讯作者Cheng, Jingqiu(jqcheng@scu.edu.cn) ; Yang, Hao(yanghao@scu.edu.cn)
英文摘要BackgroundMass spectrometry (MS) has become a promising analytical technique to acquire proteomics information for the characterization of biological samples. Nevertheless, most studies focus on the final proteins identified through a suite of algorithms by using partial MS spectra to compare with the sequence database, while the pattern recognition and classification of raw mass-spectrometric data remain unresolved. ResultsWe developed an open-source and comprehensive platform, named MSpectraAI, for analyzing large-scale MS data through deep neural networks (DNNs); this system involves spectral-feature swath extraction, classification, and visualization. Moreover, this platform allows users to create their own DNN model by using Keras. To evaluate this tool, we collected the publicly available proteomics datasets of six tumor types (a total of 7,997,805 mass spectra) from the ProteomeXchange consortium and classified the samples based on the spectra profiling. The results suggest that MSpectraAI can distinguish different types of samples based on the fingerprint spectrum and achieve better prediction accuracy in MS1 level (average 0.967).ConclusionThis study deciphers proteome profiling of raw mass spectrometry data and broadens the promising application of the classification and prediction of proteomics data from multi-tumor samples using deep learning methods. MSpectraAI also shows a better performance compared to the other classical machine learning approaches.
WOS关键词PEPTIDE IDENTIFICATION ; ACCURATE
资助项目National Natural Science Foundation of China[81871475] ; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University, Sichuan, China[ZYGD18014]
WOS研究方向Biochemistry & Molecular Biology ; Biotechnology & Applied Microbiology ; Mathematical & Computational Biology
语种英语
出版者BMC
WOS记录号WOS:000578528400003
源URL[http://119.78.100.183/handle/2S10ELR8/291477]  
专题中国科学院上海药物研究所
通讯作者Cheng, Jingqiu; Yang, Hao
作者单位1.Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Res Ct, 88 Keyuan South Rd, Chengdu 610041, Peoples R China
2.Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, MOH,Regenerat Med Res Ctr, 88 Keyuan South Rd, Chengdu 610041, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Wang, Shisheng,Zhu, Hongwen,Zhou, Hu,et al. MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks[J]. BMC BIOINFORMATICS,2020,21(1):15.
APA Wang, Shisheng,Zhu, Hongwen,Zhou, Hu,Cheng, Jingqiu,&Yang, Hao.(2020).MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks.BMC BIOINFORMATICS,21(1),15.
MLA Wang, Shisheng,et al."MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks".BMC BIOINFORMATICS 21.1(2020):15.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。